Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not met a claims data submission policy it implemented on Feb. | The drugmaker has issued a June 8 ultimatum to an unspecified number of hospitals that have resisted a data submission policy it implemented in February. Furious hospital industry groups are pushing back, calling the decision unlawful and urging the administration to intervene.

Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next five days — or lose price breaks.

Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which have until Monday to comply, are urging the government…

Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaks

Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not met a claims data submission policy it implemented on…

Eli Lilly threatens to cut 340B discounts for hospitals that won't share claims data, as the American Hospital Association calls the policy illegal.